Skip to main content

Navigation group

Type at least 3 characters
1,761 articles

Articles

Original Research

Accepted on 30 Jul 2024

The effectiveness of nirsevimab in reducing the burden of disease due to respiratory syncytial virus (RSV) infection over time in the Madrid region (Spain): a prospective population-based cohort study

in Infectious Diseases: Epidemiology and Prevention

  • José Francisco Barbas Del Buey
  • Jesús Íñigo Martínez
  • María Ángeles Gutiérrez Rodríguez
  • Marcos Alonso García
  • Amaya Sánchez Gómez
  • María Dolores Lasheras Carbajo
  • Susana Jiménez Bueno
  • María Dolores Esteban Vasallo
  • María Alejandra López Zambrano
  • Cristina Calvo Rey
Frontiers in Public Health
doi 10.3389/fpubh.2024.1441786